Based on data from the past 90 days ending January 09, 2026, Compass Therapeutics's three largest insider shareholders are Ceo Thomas J. Schuetz (6.69Mn shares), Chief Executive Officer Vered Bisker-Leib (3.12Mn shares), Director Miranda Jayne Toledano (1.79Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Thomas J. Schuetz | Ceo | 6,686,800 | 05 Jan, 2026 |
| Vered Bisker-Leib | Chief Executive Officer | 3,124,426 | 09 Feb, 2024 |
| Miranda Jayne Toledano | 1,791,549 | 29 Jun, 2021 | |
| Barry Shin | Cfo | 525,000 | 05 Jan, 2026 |
| Neil Lerner | Chief Accounting Officer | 382,500 | 05 Jan, 2026 |
| Jonathan Anderman | General Counsel | 171,000 | 05 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Neil Lerner | Common Stock | A | 62,500 | $5.17 | 382,500 | D | A |
| 02 Jan, 2026 | Thomas J. Schuetz | Common Stock | A | 250,000 | $5.17 | 6,686,800 | D | A |
| 02 Jan, 2026 | Barry Shin | Common Stock | A | 125,000 | $5.17 | 525,000 | D | A |
| 02 Jan, 2026 | Jonathan Anderman | Common Stock | A | 150,000 | $5.17 | 171,000 | D | A |
| 16 Nov, 2025 | Thomas J. Schuetz | Common Stock | D | 44,025 | $4.83 | 6,436,800 | D | F |
| 27 May, 2025 | Thomas J. Schuetz | Common Stock | A | 10,000 | $2.11 | 6,480,825 | D | P |
| 09 Apr, 2025 | Advisors Llc Orbimed | Common Stock | D | 3,571,428 | $1.59 | 0 | I | S |
| 09 Apr, 2025 | Advisors Llc Orbimed | - | - | 0 | I | |||
| 09 Apr, 2025 | Carl L Gordon | Common Stock | D | 3,571,428 | $1.59 | 0 | I | S |
| 07 Apr, 2025 | Neil Lerner | Common Stock | A | 20,000 | $1.42 | 320,000 | D | P |
| 07 Apr, 2025 | Jonathan Anderman | - | - | 21,000 | D | |||
| 07 Apr, 2025 | Jonathan Anderman | Common Stock | A | 20,000 | $1.54 | 21,000 | D | P |
| 08 Feb, 2025 | Thomas J. Schuetz | Common Stock | D | 41,687 | $3.50 | 6,470,825 | D | F |
| 09 Jan, 2025 | Thomas J. Schuetz | Common Stock | D | 58,054 | $1.86 | 6,512,512 | D | F |
| 09 Dec, 2024 | Barry Shin | - | - | 400,000 | D | |||
| 09 Dec, 2024 | Barry Shin | Common Stock | A | 400,000 | $1.65 | 400,000 | D | A |
| 08 Feb, 2024 | Thomas J. Schuetz | Common Stock | D | 44,782 | $1.45 | 6,570,566 | D | F |
| 08 Feb, 2024 | Vered Bisker-Leib | Common Stock | D | 49,198 | $1.45 | 3,124,426 | D | F |
| 09 Jan, 2024 | Thomas J. Schuetz | Common Stock | A | 637,500 | $1.93 | 6,615,348 | D | A |
| 09 Jan, 2024 | Thomas J. Schuetz | - | - | 6,615,348 | D |